Frederick G. Vogt
Interim CEO & General Counsel at Iovance Biotherapeutics · 12 reported transactions in 1 company · latest report Sep 8, 2026
Their trades
Shares withheld for tax | Sep 8, 2026 | |||
Exercised options | Sep 8, 2026 | |||
Shares withheld for tax | Jun 1, 2026 | |||
Exercised options | Jun 1, 2026 | |||
Shares withheld for tax | Dec 2, 2025 | |||
Exercised options | Dec 2, 2025 | |||
Shares withheld for tax | Dec 1, 2025 | |||
Exercised options | Dec 1, 2025 | |||
Shares withheld for tax | Sep 2, 2025 | |||
Exercised options | Sep 2, 2025 |